科学研究

News

基因修复与干细胞研究组

作者:佚名    来源:实验中心    发布时间:2018/1/8 15:14:51    点击量:    【打印文章】

团队人员

1.       研究组长:谷峰研究员,博士,研究生导师。2006年获得中国协和医科大学遗传学博士学位。2007年至2009年在美国康州大学健康中心从事人类胚胎干细胞基因表达调控研究;2009年至2012年在美国西雅图华盛顿大学从事人类胚胎干细胞基因打靶研究;2012年起在温州医科大学附属眼视光医院工作并成立基因修复与干细胞研究组。在Nucleic Acids Research ,Cell Stem Cell, Mol Ther Nucleic Acids, Human Mutation等国外杂志发表文章30篇,为英国Scientific Reports杂志和《遗传》杂志的编委,主持国家自然科学基金项目,国家卫计委,浙江省科技厅等多个项目。

2.       工作人员:葛香连、王岩、徐陶、王邦、吕秀娟

研究方向

  1. 新型基因编辑技术及应用

  2. 人类胚胎干细胞定向分化

  3. 常见遗传病的致病基因鉴定与致病机理

 

Laboratory of Gene Correction and Stem Cells

 

Team members

1.       Principle Investigator: Feng Gu, PhD

Feng Gu is an investigator of School of Ophthalmology, and Optometry, Eye Hospital, Wenzhou Medical University. He obtained his Ph.D. degree in genetics from Peking Union Medical College in 2006. From 2007-2009, he got training as a postdoctoral fellow in gene regulation and expression of human embryonic stem cell at the University of Connecticut Health Center. He then moved to Seattle and worked on gene targeting in human ES cells at University of Washington from 2009 to 2012. He joined the Eye Hospital, Wenzhou Medical University in 2012 as a Principal Investigator. His research is now supported by grants from National Natural Science Foundation of China, the National Health and Family Planning Commission of China, the grant of Zhejiang Province Science and Technology.

2.       Team Staff: Xianglian Ge, Yan Wang, Tao Xu, Bang Wang, Xiujuan Lv

 

Scope of Research Proposal

1.       Development of gene editing tools

2.       Directional differentiation of human embryonic stem cells

3.       Identification and dissection of mechanism and gene therapy for genetic disease

 


上一条:近视眼研究组